Characteristics of the sexual disturbance caused by chlorpromazine, risperidone, quetiapine and olanzapine and their associations with the changes of blood glucose and blood lipids in male patients with schizophrenia

Chinese Journal of Clinical Rehabilitation

Volumn 9, Issue 36, 2005, Pages 63-68

  Cao, Dong ^a   Xie, Shi Ping ^a   Chen, Qi Bao ^a   Yuan, Yong Gui ^a   Fang, Qun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHLORPROMAZINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLANZAPINE; QUETIAPINE; RISPERIDONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; ENZYME ANALYSIS; FUNCTIONAL ASSESSMENT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; ORGASM; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; SEXUAL AROUSAL; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TURBIDIMETRY;

EID: 31544432285     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bobes J, Garc A-Portila MP, Rejas J, et al. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol:the results of the EIRE study. J Sex Marital Ther 2003;29(2):125-47
2. Fakhoury WK, Wright D, Wallace M. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. Int Clin Psychopharmacol 2001;16(3):153-62
3. Guay AT, Spark RF, Bansal S, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction:a couple's problem-2003 update. Endocr Pract 2003;9(1):77-95
4. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15(7):539-53
5. Haupt DW, Newcomer JW. Hyperglycemia and antipsychotic medications. J Clin Psychiatry 2001;62:15-26
6. Wirshing DA, Boyd JA, Meng LR, et al. The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry 2002;63(10):856-65
7. O'Leary MP, Fowler FJ, Lenderking WR, et al. A brief male sexual function inventory for urology. Urology 1995;46(5):697-706
8. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11(6):319-26
9. Burke MA, McEvoy JP, Ritchie JC. A pilot study of a structured interview addressing sexual function in men with schizophrenia. Biol Psychiatry 1994;35 (1):32-5
10. Lingjaerde O, Ahlfors UG, Bech P, et al. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987;334:1-100
11. Meltzer HY, Matsubara S, Lee JC. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D -1,D -2 and serotonin2 pKi values. J Pharmacol Exp Ther 1989;251(1):238-46
12. Meltzer HY, Matsubara S, Lee JC. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol Bull 1989;25(3):390-2
13. Kapur S, Zipursky R, Remington G, et al. PET evidence that loxapine is an equipotent blacker of 5 -HT2 and D2 receptors: implications for the therapeutics of schizophrenia. Am J Psychiatry 1997;154(11):1525-9
14. Trichard C, Paillere-Martinot ML, Attar-Levy D, et al. Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients. Am J Psychiatry 1998;155(4)505-8
15. Carriere P, Bonhomme D, Lemperiere T. Amisulpride has a superior benefit/ risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group). Eur Psychiatry 2000;15(5):321-9
16. Kapur S, Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?:A new hypothesis. Am J Psychiatry 2001;158(3):360-9
17. Kapur S, Remington G. Dopamine D (2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry 2001;50(11):873-83
18. Kandeel FR, Koussa VK, Swerdloff RS. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev 2001;22(3):342-88
19. Smith S, Wheeler MJ, Murray R, et al. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic -pituitary -gonadal axis. J Clin Psychopharmacol 2002;22(2):109-14
20. Chinese source. 2004,14(5):268-9
21. Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 1995;44(4):369-74
22. Dev V, Raniwalla J. Quetiapine: a review of its safety in the management of schizophrenia. Drug Saf 2000;23(4):295-307